Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies

Fleseriu, M., Pivonello, R., Newell-Price, J. et al. (10 more authors) (2025) Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies. Pituitary, 28. 22. ISSN 1386-341X

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Fleseriu, M.
  • Pivonello, R.
  • Newell-Price, J.
  • Gadelha, M.R.
  • Biller, B.M.K.
  • Auchus, R.J.
  • Feelders, R.A.
  • Shimatsu, A.
  • Witek, P.
  • Bex, M.
  • Piacentini, A.
  • Pedroncelli, A.M.
  • Lacroix, A.
Copyright, Publisher and Additional Information:

© 2025 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Cushing’s disease; Osilodrostat; Cortisol normalization; Hypertension Diabetes; Long-term treatment
Dates:
  • Published: 25 January 2025
  • Published (online): 25 January 2025
  • Accepted: 12 December 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 29 Jan 2025 16:46
Last Modified: 29 Jan 2025 16:46
Published Version: https://doi.org/10.1007/s11102-024-01471-3
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number: 10.1007/s11102-024-01471-3
Open Archives Initiative ID (OAI ID):

Export

Statistics